AzurRx BioPharma (AZRX) Short Interest Ratio & Short Volume

Short interest is the volume of AzurRx BioPharma shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 1,540,000 shares of AZRX short. Learn More on AzurRx BioPharma's current short interest.

AzurRx BioPharma saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 1,540,000 shares, an increase of 43.9% from the previous total of 1,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to AzurRx BioPharma: ImmunoPrecise Antibodies Ltd. (1.48%), Fortress Biotech, Inc. (14.08%), Lexaria Bioscience Corp. (4.25%), Theratechnologies Inc. (0.06%), Aprea Therapeutics, Inc. (2.35%), Acasti Pharma Inc. (0.02%), Spruce Biosciences, Inc. (1.46%), VYNE Therapeutics Inc. (0.71%), Aptorum Group Limited (3.91%), Lipocine Inc. (2.11%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Block, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

Short selling AZRX is an investing strategy that aims to generate trading profit from AzurRx BioPharma as its price is falling. AZRX shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for AzurRx BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AZRX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AZRX, twice per month. The most recent reporting period available is August, 31 2021.